I break up with my makeup a few times per week to give my skin some time to breathe and reboot. These are the days that I stay inside or just go to the local grocery store. My skin is not the best and always has a red tinge in areas so if my sensitive skin could handle it, I would wear makeup to bed. Alas, my skin does not like most makeup and rejects most products. I have been hunting for products that my skin does not react to. It has been a tough and bumpy road.
Here are a few awesome tips that I have started working on implementing from Dr. Doris Day, board certified NYC Dermatologist and Galderma consultant.
Galderma Laboratories, L.P. has several prescription skincare products that can help treat specific issues related to rosacea and help your skin look better. Soolantra® (ivermectin) Cream, 1% is a once-daily prescription topical treatment for the inflammatory lesions, or bumps and pimples, of rosacea. Oracea® (doxycycline, USP) 40 mg Capsules is the only once daily pill for the treatment of the bumps and pimples of rosacea. Mirvaso® (brimonidine) topcial gel, 0.33% is the first and only prescription treatment specifically developed and indicated to treat the persistent facial redness of rosacea. Learn more about rosacea and treatments on the Break Up with Your Makeup page. While you’re there, be sure to enter for a chance to win an all-expense paid trip to NYC for the Fall 2015 New York Film Festival by sharing how you stay confident even on “tough skin days.” along with a no-makeup selfie.
Important Safety Information – Soolantra® Cream Indication: SOOLANTRA® (ivermectin) Cream, 1%, is indicated for the treatment of inflammatory lesions of rosacea. Adverse Events: In clinical trials with SOOLANTRA Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation. Warnings / Precautions: Not for oral, ophthalmic or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit WWW.FDA.GOV/MEDWATCH or call 1-800-FDA-1088.
Important Safety Information – Oracea® Capsules Indication: ORACEA® (doxycycline, USP) Capsules 40 mg* are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA Capsules do not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with ORACEA Capsules were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase increase. Warnings/Precautions: ORACEA Capsules should not be used to treat or prevent infections. ORACEA Capsules should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA Capsules should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not observed in clinical trials, ORACEA Capsules patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA Capsules treatment beyond 16 weeks and safety beyond 9 months have not been established. *30 mg immediate release beads and 10 mg delay released beads You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Important Safety Information – Mirvaso® Gel* Indication: Mirvaso® (brimonidine) topical gel, 0.33%* is an alpha-2 adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
*Each gram of gel contains 5mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit WWW.FDA.GOV/MEDWATCH or call 1-800-FDA-1088.
All trademarks are the property of their respective owners.
I was selected, as a member of Clever Girls, to post on behalf of the Break Up with Your Makeup program sponsored by Galderma Laboratories, L.P. The content and opinions expressed here are my own. You should discuss any medication with your doctor.